Preoperative High Dose of Methylprednisolone Improves Early Postoperative Pulmonary Function, in Super-Obese Patients

George Skroubis1, George Theofanis2, Charalampos Spyropoulos2

  • 1Morbid Obesity Unit, Department of Surgery, University Hospital of Patras, Rion Patras, 26504, Patras, Greece. skroubis@med.upatras.gr.

Abstract

Insights

Methylprednisolone administration before surgery in super-obese patients reduced inflammatory markers and improved recovery. This treatment led to better pulmonary function and less pain, nausea, and vomiting post-operation.

Area of Science:

  • Pharmacology and surgical outcomes
  • Inflammation and immune response modulation

Background:

  • Surgery triggers a significant systemic inflammatory response, potentially increasing postoperative complications.
  • Corticosteroids are known to mitigate inflammatory reactions.

Purpose of the Study:

  • To evaluate the impact of methylprednisolone on postoperative morbidity and recovery in super-obese patients undergoing open surgery.
  • To investigate the anti-inflammatory effects of methylprednisolone in this specific patient population.

Main Methods:

  • A randomized controlled trial involving sixty super-obese patients (BMI ≥50 kg/m²) undergoing open bariatric surgery.
  • Patients received either a single preoperative dose of methylprednisolone (30 mg/kg ideal body weight) or a placebo.
  • Key endpoints included inflammatory markers (IL-6, CRP), pulmonary function, pain, nausea, vomiting, and complications.

Main Results:

  • The methylprednisolone group showed significant improvements in spirometry and arterial blood gas analysis on postoperative days 1 and 3.
  • Interleukin-6 (IL-6) and C-reactive protein (CRP) levels were significantly lower in the methylprednisolone group.
  • Reduced postoperative pain, nausea, and vomiting were observed with methylprednisolone, without an increase in septic complications.

Conclusions:

  • Preoperative methylprednisolone effectively inhibits the inflammatory cascade in super-obese patients undergoing open surgery.
  • This intervention leads to a lessened systemic inflammatory response, fewer pulmonary complications, and enhanced patient recovery.
  • A single high dose of methylprednisolone is a promising strategy for improving surgical outcomes in super-obese individuals.